Response to Pegylated Interferon Plus Ribavirin Among HIV/Hepatitis C Virus-Coinfected Patients With Compensated Liver Cirrhosis-Reference-Cited by-同舟云学术

Response to Pegylated Interferon Plus Ribavirin Among HIV/Hepatitis C Virus-Coinfected Patients With Compensated Liver Cirrhosis

Published:2012-09-05 Issue:12 Volume:55 Page:1719-1726
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clinical Infectious Diseases

Author:

Mira J. A.,Garcia-Rey S.,Rivero A.,de los Santos-Gil I.,Lopez-Cortes L. F.,Giron-Gonzalez J. A.,Tellez F.,Marquez M.,Merino D.,Rios-Villegas M. J.,Macias J.,Rivero-Juarez A.,Pineda J. A.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/55/12/1719/1252060/cis779.pdf

Reference23 articles.

1. Causes of Death in HIV‐1–Infected Patients Treated with Antiretroviral Therapy, 1996–2006: Collaborative Analysis of 13 HIV Cohort Studies

2. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol

3. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy

4. Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta‐Analysis

5. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictor factors of sustained virological response in patients with chronic hepatitis C treated with current direct-acting antiviral drugs;Tropical Journal of Pharmaceutical Research;2020-11-24

2. HIV/HCV Coinfection: Current Challenges;Viral Hepatitis: Chronic Hepatitis C;2019

3. Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients – French ANRS CO13 HEPAVIH cohort;Journal of Hepatology;2017-07

4. Liver stiffness predicts the response to direct-acting antiviral-based therapy against chronic hepatitis C in cirrhotic patients;European Journal of Clinical Microbiology & Infectious Diseases;2016-12-21

5. Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients;Annals of Internal Medicine;2016-10-18